NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Thursday, February 14th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share on Tuesday, March 19th. This represents a $0.76 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Thursday, February 28th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) posted its earnings results on Thursday, August, 9th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.01. The firm earned $1.19 billion during the quarter, compared to analysts' expectations of $1.23 billion. Perrigo had a net margin of 2.54% and a return on equity of 11.32%. The company's revenue was down 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.22 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Perrigo.

13 brokers have issued 1 year price objectives for Perrigo's shares. Their predictions range from $46.00 to $110.00. On average, they expect Perrigo's share price to reach $77.3571 in the next twelve months. This suggests a possible upside of 58.0% from the stock's current price. View Analyst Price Targets for Perrigo.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Media headlines about PRGO stock have been trending somewhat positive this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a coverage optimism score of 1.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future.

Perrigo saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 5,474,515 shares, a drop of 37.7% from the December 14th total of 8,791,586 shares. Based on an average daily volume of 3,537,573 shares, the short-interest ratio is presently 1.5 days. Approximately 4.0% of the company's stock are sold short. View Perrigo's Current Options Chain.

Some companies that are related to Perrigo include Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Mylan (MYL), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Genmab A/S (GNMSF), Sarepta Therapeutics (SRPT), Bausch Health Companies (BHC), Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS), Beigene (BGNE) and Jazz Pharmaceuticals (JAZZ).

Perrigo's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.23%), Clal Insurance Enterprises Holdings Ltd (1.74%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.29%), Geode Capital Management LLC (1.24%), Dimensional Fund Advisors LP (1.07%) and Northern Trust Corp (1.06%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Iridian Asset Management LLC CT, Parnassus Investments CA, Manning & Napier Group LLC, Mackenzie Financial Corp, Menora Mivtachim Holdings LTD., Canada Pension Plan Investment Board and Thrivent Financial for Lutherans. View Insider Buying and Selling for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Dimensional Fund Advisors LP, Clal Insurance Enterprises Holdings Ltd, First Trust Advisors LP, Geode Capital Management LLC, TD Asset Management Inc., BlackRock Inc. and Macquarie Group Ltd.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $48.95.

Perrigo has a market capitalization of $6.65 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]